Related Experiment Video
Updated: Dec 13, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management
Yasar Sattar1, Waqas Ullah2, Hiba Rauf3
1Internal Medicine, Icahn School of Medicine at Mount Sinai - Elmhurst Hospital, NY, USA.
Insights
Coronavirus Disease 2019 (COVID-19) causes various cardiac issues, especially in those with prior heart conditions. This review covers COVID-19
Area of Science:
- Cardiology
- Infectious Diseases
- Pathophysiology
Background:
- Coronavirus Disease 2019 (COVID-19) is a global pandemic.
- Cardiovascular manifestations are common in COVID-19 patients.
- Pre-existing cardiac conditions exacerbate COVID-19's cardiac effects.
Purpose of the Study:
- To review the cellular pathophysiology of cardiac manifestations in COVID-19.
- To outline the clinical presentations of cardiac involvement in COVID-19.
- To discuss treatment strategies for COVID-19-related cardiac conditions.
Main Methods:
- Literature review of cellular pathophysiology.
- Analysis of clinical manifestations.
- Summary of current treatment modalities.
Main Results:
- COVID-19 can lead to myocardial injury, infarction, arrhythmias, heart failure, cardiomyopathy, shock, thromboembolism, and cardiac arrest.
- Patients with coronary artery disease, hypertension, diabetes, and coagulation disorders face worse outcomes.
- Advanced age and immunocompromised states are significant risk factors.
Conclusions:
- Understanding the pathophysiology is crucial for managing cardiac complications.
- Early recognition and tailored treatment are essential for improving patient outcomes.
- Multidisciplinary approaches are needed to address the complex cardiac sequelae of COVID-19.
Abstract:
Coronavirus Disease 2019 (COVID-19) is a rapidly progressing global pandemic that may present with a variety of cardiac manifestations including, but not limited to, myocardial injury, myocardial infarction, arrhythmias, heart failure, cardiomyopathy, shock, thromboembolism, and cardiac arrest. These cardiovascular effects are worse in patients who have pre-existing cardiac conditions such as coronary artery disease, hypertension, diabetes mellitus, and coagulation abnormalities. Other predisposing risk factors include advanced age, immunocompromised state, and underlying systemic inflammatory conditions. Here we review the cellular pathophysiology, clinical manifestations and treatment modalities of the cardiac manifestations seen in patients with COVID-19.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Myocarditis III: Medical Management
Endocarditis III: Medical Management
Coronary Artery Disease II: Pathophysiology

